par Neymark, Niels;Gorlia, Thierry;Adriaenssen, Ines;Baron, Benoît;Piccart-Gebhart, Martine 
Référence PharmacoEconomics, 20, 7, page (485-497)
Publication Publié, 2002

Référence PharmacoEconomics, 20, 7, page (485-497)
Publication Publié, 2002
Article révisé par les pairs
| Titre: |
|
| Auteur: | Neymark, Niels; Gorlia, Thierry; Adriaenssen, Ines; Baron, Benoît; Piccart-Gebhart, Martine |
| Informations sur la publication: | PharmacoEconomics, 20, 7, page (485-497) |
| Statut de publication: | Publié, 2002 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antineoplastic Combined Chemotherapy Protocols -- economics |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Cisplatin -- administration & dosage | |
| Cost-Benefit Analysis | |
| Cyclophosphamide -- administration & dosage | |
| Female | |
| Health Care Costs | |
| Humans | |
| Ovarian Neoplasms -- drug therapy | |
| Ovarian Neoplasms -- mortality | |
| Paclitaxel -- administration & dosage | |
| Note générale: | Clinical Trial |
| Comparative Study | |
| Journal Article | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1170-7690 |
| info:doi/10.2165/00019053-200220070-00006 | |
| info:pii/200706 | |
| info:scp/0036071038 | |
| info:pmid/12093304 |



